What: Stateline’s Nada Hassanein investigates coverage for the first postpartum depression drug and finds that only 17 insurers–less than 1 percent of the 1,000 insurance companies in the country–have published coverage guidance. The new medication, Zurzuvae, recently hit the market and costs $16,000.
Why it matters: As Hassanein reports, Medicaid covers 41% of births nationwide, and many state Medicaid agencies haven’t yet said if they’ll cover the medication. Which means many women who may need this drug can’t get it yet.
Source: Stateline